Medicare will announce negotiated prices for 15 high-cost drugs, impacting over 67 million beneficiaries. The Inflation ...

Although CNPVs are widely viewed as a valuable opportunity, the criteria for selection remain somewhat opaque. One of the program’s stated goals is to bolster domestic drug production, particularly ...

A new Pharma Pulse briefing unpacks declining RSV vaccine durability in older adults, AstraZeneca’s $2 billion expansion of its US biologics manufacturing footprint, and the stock-shaking Phase III ...

Manufacturers now face a rapidly evolving landscape where tariffs can shift overnight—from metals to paper to other key ...

In today’s demanding clinical development environment—marked by complex protocols, tightened budgets, and heightened scrutiny from regulators, payers, and patients—fragmented trial planning puts ...

Moderna secured a $1.5 billion loan from Ares Management, structured in three tranches, to enhance financial flexibility and ...